First, CD203c can be employed as a new prognostic basophil marker in CML, especially when microscopic studies reveal the presence of immature basophils, such as in accelerated phase CML (AP) or in patients with massive left shifting in differential counts. The gene discussed is ENPP3; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.